Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Get Free Report) saw a significant increase in short interest in the month of June. As of June 15th, there was short interest totalling 5,629,300 shares, an increase of 7.6% from the May 31st total of 5,231,800 shares. Based on an average daily volume of 598,200 shares, the short-interest ratio is currently 9.4 days.
Curaleaf Stock Down 2.6 %
Shares of Curaleaf stock opened at $3.78 on Wednesday. The company’s fifty day simple moving average is $4.77 and its two-hundred day simple moving average is $4.80. Curaleaf has a 12-month low of $2.51 and a 12-month high of $6.40. The company has a current ratio of 0.72, a quick ratio of 0.36 and a debt-to-equity ratio of 0.74. The company has a market cap of $2.45 billion, a P/E ratio of -9.69 and a beta of 0.89.
Curaleaf (OTCMKTS:CURLF – Get Free Report) last released its quarterly earnings results on Thursday, May 9th. The company reported ($0.07) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.01). Curaleaf had a negative return on equity of 14.43% and a negative net margin of 20.29%. The company had revenue of $338.93 million during the quarter, compared to the consensus estimate of $341.25 million. Research analysts anticipate that Curaleaf will post -0.2 EPS for the current year.
Wall Street Analysts Forecast Growth
Get Our Latest Stock Analysis on Curaleaf
Curaleaf Company Profile
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Read More
- Five stocks we like better than Curaleaf
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- RXO Shares Surge Following New Acquisition Deal
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- Roth IRA Calculator: Calculate Your Potential Returns
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
